ARTICLE | Company News
Centre for Drug Research and Development, Zucara Therapeutics deal
October 24, 2016 7:00 AM UTC
Zucara and the center partnered to develop preclinical somatostatin receptor 2 (SSTR2) antagonists. Zucara plans to start Phase I trials to treat hypoglycemia in patients with diabetes in 2018. As par...